Naldemedine - Shionogi
Alternative Names: Naldemedine Tosilate; Rizmoic; S-297995; SymproicLatest Information Update: 10 Jun 2025
At a glance
- Originator Shionogi
- Developer Purdue Pharma; Shionogi
- Class Antiemetics; Laxatives; Small molecules
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Marketed Constipation
- Discontinued Postoperative ileus